Bone marrow cell therapy in hypertensive kidney disease: Contribution to cardiac fibrosis?

Journal of Hypertension

Volumn 31, Issue 5, 2013, Pages 1052-1054

  Van Koppen, Arianne ^a   Joles, Jaap A ^a   Verhaar, Marianne C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW CELL; CELL THERAPY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HYPERTENSION; KIDNEY FUNCTION; LETTER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; RENOVASCULAR HYPERTENSION;

EID: 84876228112     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835fdf87     Document Type: Letter

References (5)

1. Keeley EC, Mehrad B, Janardhanan R, Salerno M, Hunter JR, Burdick MM, et al. Elevated circulating fibrocyte levels in patients with hypertensive heart disease. J Hypertens 2012; 30:1856-1861.
2. Simko F, Paulis L. Hypertensive heart disease: bone marrow as a significant player in pathologic remodelling? J Hypertens 2012; 30: 1702-1705.
3. van Koppen A, Joles JA, Bongartz LG, van den BJ, Reichardt HM, Goldschmeding R, et al. Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease. Cell Transplant 2012; 21:2299-2312.
4. Bongartz LG, Braam B, Gaillard CA, Cramer MJ, Goldschmeding R, Verhaar MC, et al. Target organ cross talk in cardiorenal syndrome: animal models. Am J Physiol Renal Physiol 2012; 303:F1253-F1263.
5. van den Brandt J, Wang D, Kwon SH, Heinkelein M, Reichardt HM. Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo. Genesis 2004; 39:94-99.